|
**Overview**: Allergy Grass Panel**Introduction**: The Allergy Grass Panel is a diagnostic tool designed to screen for grass pollen allergies using serum samples. In India, grass pollen sensitization is significant in seasonal allergic rhinitis and asthma, with common species including Bermuda, Timothy, Johnson, Rye, and Meadow grass contributing to symptoms in pollen-sensitive regions (prevalence 10-25 percent in rhinitis cohorts). Symptoms include sneezing, nasal congestion, eye itching, wheezing, and exacerbations during spring/summer pollen seasons. High morbidity from underdiagnosis in rural/agricultural areas, limited access to testing, and overlap with viral infections. Per immunology practices (ICMR aligned), the test employs immunoassay for detailed parameter analysis over 1-2 days with high sensitivity/specificity, valuable for identifying grass triggers in seasonal cases. This diagnostic falls under allergy screening and targets individuals with suspected grass pollen allergies, addressing accurate detection to guide avoidance, pharmacotherapy, or immunotherapy. With morbidity elevated due to underdiagnosis in pollen-exposed populations, the test supports public health efforts by enabling precise identification, facilitating management, and reducing seasonal exacerbations. Its serum-based approach ensures reliable detection.**Other Names**: Grass Pnl.**FDA Status**: FDA approved, CLIA certified for immunology, compliant with 2025 standards.**Historical Milestone**: Expanded with specific IgE testing; in India, relevance with seasonal grass pollen exposure.**Purpose**: The test screens for 6 parameters including Bermuda grass IgE to guide grass allergy assessment, identify triggers, inform treatment strategies.**Test Parameters**: 1. Bermuda Grass IgE, 2. Timothy Grass IgE, 3. Johnson Grass IgE, 4. Rye Grass IgE, 5. Meadow Grass IgE, 6. Total IgE.**Pretest Condition**: No fasting required; patients should report seasonal sneezing, nasal congestion, eye itching, or asthma worsening.**Specimen**: 3 mL serum in 1 SST, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 8 hours with proper handling to preserve analyte integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.**Medical History**: Patients should provide details on symptom seasonality, outdoor exposure, pollen seasons, or family atopy.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of untreated grass allergies including chronic rhinitis or asthma, benefits of early detection, and minimal discomfort from venipuncture.**Procedural Considerations**: The test involves sample processing using immunoassay by trained personnel to ensure sterile technique, avoid hemolysis, and interpret results within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols, and store kits according to manufacturer specifications to ensure reliability.**Factors Affecting Result Accuracy**: Delays beyond stability periods, improper storage conditions, hemolysis, or concurrent infections can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Abnormal results indicate possible grass pollen triggers, necessitating further investigation like specialist consultation or additional testing. Normal results may require follow-up if symptoms persist.**Specialist Consultation**: Allergists or pulmonologists should be consulted for case management, treatment planning, and coordination with health programs.**Additional Supporting Tests**: Pollen count correlation or skin prick test for confirmation.**Test Limitations**: The test may produce false negatives in off-season or false positives in sensitization without clinical disease, requiring a comprehensive diagnostic approach that includes clinical correlation.**References**: Indian Journal of Allergy Asthma Immunology 2024, Pollen Allergen Studies India 2023. |
